(Q34133456)

31 July 2017

1 reference

title

Probiotic bacteria: safety, functional and technological properties (English)

1 reference

31 July 2017

0 references

0 references

Saarela M

1

1 reference

31 July 2017

Mogensen G

2

1 reference

31 July 2017

Fondén R

3

1 reference

31 July 2017

Mättö J

4

1 reference

31 July 2017

Mattila-Sandholm T

5

1 reference

31 July 2017

1 December 2000

1 reference

31 July 2017

Journal of Biotechnology

1 reference

31 July 2017

84

1 reference

31 July 2017

3

1 reference

31 July 2017

197-215

1 reference

Safety of industrial lactic acid bacteria

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Recovery of Lactobacillus rhamnosus GG from human colonic biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antibiotic susceptibility of potentially probiotic Lactobacillus species.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Ingredient supplementation effects on viability of probiotic bacteria in yogurt

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Anticarcinogenic and Immunological Properties of Dietary Lactobacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Probiotics in man and animals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

The development of functional foods: lessons from the gut.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Survival of Lactobacillus species (strain GG) in human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Growth enhancement of Bifidobacterium lactis Bo and Lactobacillus acidophilus Ki by milk hydrolyzates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Biological preservation of foods with reference to protective cultures, bacteriocins and food-grade enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antimutagenic properties of lactic acid-cultured milk on chemical and fecal mutagens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

New functional foods in the treatment of food allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Oral bacteriotherapy for viral gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

The ability of probiotic bacteria to bind to human intestinal mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactobacillus rhamnosus GG (ATCC 53103) and platelet aggregation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactobacilli, anticarcinogenic activities and human intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antimicrobial susceptibility of bifidobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactobacillus endocarditis caused by a probiotic organism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Probiotics: a novel approach in the management of food allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactic acid bacteria with health claims—interactions and interference with gastrointestinal flora

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Activity of glycopeptides against vancomycin-resistant gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Microbiological evaluation of jejunal aspirates and faecal samples after oral administration of bifidobacteria and lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

New types of antimicrobial compounds produced by Lactobacillus plantarum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase III, multicenter, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Characterization of plasmids and plasmid-borne macrolide resistance from Lactobacillus sp. strain 100-33

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Vancomycin-resistant enterococci isolated from animals and food

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Demonstration of safety of probiotics -- a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antimicrobial substance from a human Lactobacillus strain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Microbiological and technological aspects of milks fermented by bifidobacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antimutagenicity of Lactic Acid Bacteria from "Idly" Against Food-Related Mutagens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Binding properties of lactic acid bacteria from 'Idly' towards food-borne mutagens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Human ileostomy glycoproteins as a model for small intestinal mucus to investigate adhesion of probiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Safety and Tolerance of Lactobacillus reuteri in Healthy Adult Male Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antimutagenicity of cell fractions of microorganisms on potent mutagenic pyrolysates.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

Antimutagenicity and binding of lactic acid bacteria from a Chinese cheese to mutagenic pyrolyzates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900375-8

7 January 2021

10.1016/S0168-1656(00)00375-8

Identifiers

DOI

1 reference

31 July 2017

1 reference